logo
Plus   Neg
Share
Email

Stock Alert: NextCure Tumbles To New 52-week Low

Shares of NextCure, Inc. (NXTC) are losing more than 41 percent or $7.36 in Monday's morning trade at $10.52, after earlier touching a new 52-week low of $10.45.

Monday, Beltsville, Maryland-based NextCure NextCure provided an interim update of the Phase 2 portion of its NC318 Monotherapy phase 1/2 trial.

NextCure said that based on current enrolment criteria and clinical response data, it does not plan to advance the non-small cell lung cancer or NSCLC and ovarian cancer cohorts into the stage 2 portion of the Simon 2-stage trial. The biotechnology company noted that the analysis of biomarker data for these cohorts has been delayed and is not yet complete.

In addition, NextCure said that its chief medical officer Kevin Heller has resigned, effective August 4, 2020 to pursue a new opportunity. Dr. Heller will serve as a consultant to the company. The company has initiated a search for a new chief medical officer.

NextCure has traded in a range of $10.45 to $109.00 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Biotech company Illumina agreed to buy healthcare company GRAIL, Inc. in a cash and stock deal valued at $8 billion. This includes $3.5 billion in cash and $4.5 billion in shares of Illumina common stock. GRAIL focuses on multi-cancer early detection from blood. It is in the process of developing the technology and providing clinical data required to launch the Galleri multi-cancer screening test. Oracle and Walmart have tentatively agreed to acquire 20% of the newly formed TikTok Global business, the companies said in a statement. Amid the growing climate crisis, Walmart said it is raising its ambition to zero emissions by 2040, without the use of carbon offsets, across its global operations. The retail giant, along with the Walmart Foundation, also committed to help protect, manage or restore at least 50 million acres of land and one million square miles of ocean by 2030.
RELATED NEWS
Follow RTT